Search CHE
CHEMED CORP
NYSE · CIK 19584
Last close507.5
Daily change+4.60 (0.91%)
10 Years gain+272.91%
Dividends TTM2.5 (+19.05%)
Dividend yield0.50%
Fundamental Analysis
CHE · STANDARD
SIC 8082 · Services-Home Health Care Services · Fiscal year end 1231
Fundamental
72.7Momentum
n/aAcceleration
n/aConfidence
90.0Annual Revenue18
Quarterly Revenue55
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth24.5 / 25
Quality15.4 / 25
Capital Efficiency10.8 / 20
Balance Sheet8.5 / 15
Shareholder Economics9.8 / 10
Forward Indicators0.0 / 5
Signals
Share count reductionDiluted share count declined 10.6001%.
Key Metrics
Revenue Growth TTM45.7%OK
Revenue CAGR 3Y28.17%OK
Gross Margin31.81%OK
Operating Margin12.3%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC24.47%OK
Incremental Operating Margin 3Y-2.01%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-10.6%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.53B | $823.18M | $338.25M | $388.27M | $325.48M | 32.54% | 13.37% | 12.86% | 27.33% | 14.46M |
| 2025 FY Dec 31, 2024 | n/a | $2.43B | $366.49M | $417.50M | $367.97M | n/a | n/a | n/a | n/a | 15.19M |
| 2024 FY Dec 31, 2024 | $1.53B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2025 FY Dec 31, 2023 | n/a | $2.26B | $340.57M | $330.30M | $273.45M | n/a | n/a | n/a | n/a | 15.2M |
| 2024 FY Dec 31, 2023 | $1.32B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.57B | sum latest 4 fiscal quarters Revenue | OK | 0000019584-26-000020, 0000019584-25-000006 |
| Revenue Growth TTM | 45.7% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000019584-26-000020, 0000019584-25-000006 |
| Revenue CAGR 3Y | 28.17% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001562762-26-000020 |
| Revenue CAGR 5Y | 13.64% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001562762-26-000020 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001562762-26-000020 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0000019584-26-000020, 0000019584-25-000006 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 31.81% | Gross Profit / Revenue | OK | 0000019584-26-000020, 0000019584-25-000006 |
| Operating Margin | 12.3% | Operating Income / Revenue | OK | 0000019584-26-000020, 0000019584-25-000006 |
| ROIC | 24.47% | NOPAT / Average Invested Capital | OK | 0000019584-26-000020, 0000019584-25-000006 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000019584-26-000020 |
| Interest Coverage | 98.91x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 0.91x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.29x | (Cash + Short-term Investments) / Total Debt | OK | 0000019584-26-000020 |